Position in JNJ
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,145,658
+$110,455 QoQ
Shares Held
4,511
+6.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#2,883
of 4,676 holders
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EWA, LLC holds $7,685,441 across 8 Drug Manufacturers - General names. JNJ ranks #2 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,662 | $3,192,882 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
4,511 | $1,145,658 | |
| 3 | ABBV |
AbbVie Inc.
|
3,645 | $917,227 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,403 | $565,785 | |
| 5 | AZN |
Astrazeneca PLC
|
2,740 | $519,558 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,938 | $497,526 | |
| 7 | NVS |
Novartis AG
|
2,790 | $437,248 | |
| 8 | AMGN |
Amgen Inc
|
1,131 | $409,557 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,145,658 | 4,511 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,035,203 | 4,235 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $665,758 | 3,217 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $545,876 | 2,944 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $436,865 | 2,860 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $374,135 | 2,256 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $324,816 | 2,246 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $364,148 | 2,247 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $286,035 | 1,957 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $256,584 | 1,622 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $209,548 | 1,266 | Shares | Sole | 2023-08-10 | |
| No filing history on record for this holder in this stock. | ||||||